MSD

News

JPM: Illumina launches 'unprecedented' disease biology atlas

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.

News

Spinning top in black and white, revolving

Report says MSD is in talks to buy Revolution Meds

MSD is rumoured to be in talks to buy Revolution Medicines and its KRAS inhibitor pipeline in a deal that could be worth up to $32 billion.

News

Nine more companies sign pricing deals with Trump

Nine more pharma groups have agreed to lower the costs of medicines in the US under the Trump administration's most favoured nation (MFN) scheme.

News

MSD claims two national priority vouchers; report

The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD drug candidates.

News

Padcev/Keytruda scores again in early bladder cancer

Pfizer and Astellas now have two studies supporting the use of Padcev with MSD's Keytruda as perioperative therapy for muscle-invasive bladder cancer.

News

Are RSV shots next in line for restrictions in the US?

After pushing for restrictions on vaccines for COVID-19 and hepatitis B, the Trump administration seems to be turning its attention to RSV shots.

JPM: Illumina launches 'unprecedented' disease biology atlas

Report says MSD is in talks to buy Revolution Meds

Nine more companies sign pricing deals with Trump

MSD claims two national priority vouchers; report

Padcev/Keytruda scores again in early bladder cancer

Are RSV shots next in line for restrictions in the US?

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

MSD

Editor's Picks